Fig. 2
From: Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features
A 65-year-old male with HCC in the nonresponse group. A, B and C (arterial phase, portal phase and delayed phase), The tumor in segment VII with a maximum diameter of 5.0 cm had irregular margins (white arrow) on preoperative MR imaging. D (Digital subtraction angiography (DSA) before TACE, Proper hepatic artery injection demonstrating one hypervascular tumor located in the right liver (white arrow). E (Digital subtraction angiography (DSA) after TACE, Post-TACE DSA with no tumor blush (white arrow). F, one month after TACE treatment, enhanced tissue on MR imaging indicated the tumor was viable (SD)